Ivonne Cantu
Director/Board Member chez PRIMARY HEALTH PROPERTIES PLC
Fortune : 83 690 $ au 31/03/2024
Profil
Ivonne Cantu is currently an Independent Non-Executive Director at Primary Health Properties Plc and Creo Medical Ltd.
She also holds the position of Director-Investor Relations & Sustainability at Benchmark Holdings Plc.
In addition, she serves as a Trustee at La Vida (United Kingdom).
Ms. Cantu completed her undergraduate degree at Universidad Panamericana and holds an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CREO MEDICAL GROUP PLC
0,03% | 09/03/2023 | 125 000 ( 0,03% ) | 54 083 $ | 31/03/2024 |
| 31/12/2023 | 25 000 ( 0,00% ) | 29 608 $ | 31/03/2024 |
Postes actifs de Ivonne Cantu
| Sociétés | Poste | Début |
|---|---|---|
| BENCHMARK HOLDINGS PLC | Investor Relations Contact | - |
| CREO MEDICAL GROUP PLC | Director/Board Member | 01/02/2020 |
| PRIMARY HEALTH PROPERTIES PLC | Director/Board Member | 01/12/2021 |
Creo Medical Ltd.
 Creo Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Creo Medical Ltd. develops, manufactures and commercializes medical device technologies. It offers CROMA system, an electrosurgical unit that delivers bipolar radiofrequency power for the purpose of cutting, and microwave power for the purpose of coagulating tissue to staunch bleeding vessels. The firm also offers RS2 instrument, a retractable injection needle for tissue lift and irrigation. The company was founded by Christopher Paul Hancock and Steven Morris in 2003 and is headquartered in Chepstow, the United Kingdom. | Director/Board Member | 01/02/2020 |
| La Vida (United Kingdom) | Director/Board Member | - |
Formation de Ivonne Cantu
| Universidad Panamericana | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PRIMARY HEALTH PROPERTIES PLC | Finance |
| BENCHMARK HOLDINGS PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Creo Medical Ltd.
Creo Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Creo Medical Ltd. develops, manufactures and commercializes medical device technologies. It offers CROMA system, an electrosurgical unit that delivers bipolar radiofrequency power for the purpose of cutting, and microwave power for the purpose of coagulating tissue to staunch bleeding vessels. The firm also offers RS2 instrument, a retractable injection needle for tissue lift and irrigation. The company was founded by Christopher Paul Hancock and Steven Morris in 2003 and is headquartered in Chepstow, the United Kingdom. | Electronic Technology |
| Creo Medical Group Plc | |
| La Vida (United Kingdom) |
